Billing Codes

73337

A test of tumour tissue from a patient with a new diagnosis of non-small cell lung cancer, requested by, or on behalf of, a specialist or consultant physician, if the test is: (a) for epidermal growth factor receptor (EGFR) status to determine eligibility for a relevant treatment under the Pharmaceutical Benefits Scheme; and (b) not associated with a service to which item 73437 or 73438 applies

Schedule fee
$397.35
was $397.35
100% Benefit
85%: $337.75
75%: $298.05
Category
Category 6 — Pathology
Group P7
Status
Unchanged
Full description

A test of tumour tissue from a patient with a new diagnosis of non-small cell lung cancer, requested by, or on behalf of, a specialist or consultant physician, if the test is: (a) for epidermal growth factor receptor (EGFR) status to determine eligibility for a relevant treatment under the Pharmaceutical Benefits Scheme; and (b) not associated with a service to which item 73437 or 73438 applies

Fee history

Release Change Old New
November 2025 UPDATED $397.35 $397.35

Data sourced from Australian Government publications · Not an official government service